Representative before the EPO

Company dna lbkpatent aps
no operation time available
202.87
1 office
active in Legal Services

Lars Bo Kjerrumgaard has worked on the following 11 EPO patent applications which have been published in the last five years:

EP11195866

Pedal adaptor for a bicycle pedal

IPC classification:
B62M 3/08
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12152413

Novel galactoside inhibitors of galectins

IPC classification:
A61K 31/7028, A61P 19/02, A61P 29/00, A61P 35/00, C07H 15/18
Agent:
Maria Elisabeth Stenbäck, Awapatent AB
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14174953

Novel 3-triazolyl-galactoside inhibitors of galectins

IPC classification:
A61K 31/7056, A61P 19/02, A61P 29/00, A61P 35/00, C07H 19/056
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13700935

NOVEL GALACTOSIDE INHIBITORS OF GALECTINS

IPC classification:
A61K 31/7028, A61P 19/02, A61P 29/00, A61P 35/00, C07H 15/18
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13785446

GALACTOSIDE INHIBITOR OF GALECTIN-3 AND ITS USE FOR TREATING PULMONARY FIBROSIS

IPC classification:
A61K 9/00, A61K 31/70, A61K 31/7056, A61M 11/00, A61M 15/00, A61P 11/00
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
EXAMINATION IN PROGRESS
EP13855895

METHODS, COMPOSITIONS AND KITS FOR TREATING, MODULATING, OR PREVENTING OCULAR ANGIOGENESIS OR FIBROSIS IN A SUBJECT USING A GALECTIN PROTEIN INHIBITOR

IPC classification:
A61K 31/70, A61K 31/732, A61K 38/17, A61P 27/02
Applicant:
Tufts University
Agent:
HGF Limited
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
GRANT OF PATENT INTENDED
EP13819021

SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE

IPC classification:
A61K 9/107, A61K 9/20, A61K 9/66, A61K 47/14, A61K 47/44
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
The patent has been granted
EP14728388

TURBINE BLADE

IPC classification:
F03D 3/06
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15700474

SOLID ORAL DOSAGE FORM OF IRINOTECAN FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/4745, A61P 35/00, C07D 491/22
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
EXAMINATION IN PROGRESS
EP15715235

GALACTOSIDE INHIBITORS FOR THE TREATMENT OF ALPHA-SYNUCLEINOPTHIES

IPC classification:
A61K 31/7056, A61P 25/16, A61P 25/26
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
EXAMINATION REQUESTED
EP15734170

NOVEL HYBRID GALACTOSIDE INHIBITOR OF GALECTINS

IPC classification:
A61K 31/7008, A61K 31/7042, A61P 29/00, C07H 13/04, C07H 13/08, C07H 15/26
Agent:
Lars Bo Kjerrumgaard, LBKPATENT ApS
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature